Januvia Heart Risks Not Seen in New Study for Diabetes Drug
A new study failed to find links between Januvia and increased cardiovascular risks.…
«
»
A new study failed to find links between Januvia and increased cardiovascular risks.…
An FDA advisory panel has voted to add new label warnings to the diabetes drug Nesina.…
An FDA advisory committee is calling on the agency to add new warning labels to the diabetes drug Onglyza, including warnings of risks of heart failure and death.…
FDA reviewers warn that the diabetes drug Onglyza may increase the risk of death in some patients.…
A new study links blood glucose levels to an increased risk of pancreatic cancer.…
A new report highlights problems with the FDA’s drug approval and postmarketing monitoring processes, focusing on the side effects of diabetes drugs like Byetta, Januvia and Victoza.…
A federal judge has rejected a call for access to source data on adverse event reports tied to some diabetes drugs and pancreatic cancer, saying it would lead to the court overstepping its bounds.…
The FDA has approved a new diabetes drug, Trulicity, that may carry similar thyroid and pancreatic cancer risks as existing diabetes treatments.…
AstraZeneca announced it has settled 84 Byetta lawsuits, but still faces more than 400 claims involving allegations that the diabetes drug caused pancreatic cancer, thyroid cancer or pancreatitis.…
Following a status conference, deadlines for discovery have been established in the pancreatic cancer lawsuits.…